The Greater Cannabis Company, Inc. reported a net loss of $669,369 for the nine months ending September 30, 2025, compared to a loss of $135,693 during the same period in 2024. The company did not generate any revenue from product sales or consulting fees in the current fiscal period, mirroring the previous year’s performance. Operating expenses increased to $129,199 from $118,651, primarily due to higher other operating expenses and stock-based compensation. The basic and diluted loss per share for the nine months was $0.85, compared to $0.25 in the prior year.
In terms of financial position, total assets decreased to $21,355 as of September 30, 2025, down from $57,785 at the end of 2024. Current liabilities rose to $1,129,697, up from $898,058, largely driven by increased accrued officers’ compensation and note default penalties. The company’s accumulated deficit also widened to $5,329,714 from $4,660,345, reflecting ongoing operational challenges and financial losses.
The company’s operational metrics indicate a significant increase in the number of common shares outstanding, which rose to 900,256 from 536,622. This increase was attributed to the issuance of shares for the conversion of notes payable and compensation. However, the company did not report any customer counts or product adoption rates, indicating a lack of market penetration or engagement during the reporting period. The absence of revenue generation raises concerns about the company’s market share and overall business viability.
Strategically, Greater Cannabis has not disclosed any significant acquisitions or product launches in the recent filing. The company continues to face challenges in securing additional financing to support its growth plans and operations. The management has acknowledged the risks associated with their business model, including the potential inability to remediate identified weaknesses in internal controls and the uncertainty surrounding future profitability.
Looking ahead, the company has not provided specific forward-looking statements regarding its operational or financial outlook. However, it has indicated that various factors, including market conditions and the ability to attract qualified personnel, will significantly influence its future performance. The management cautions that actual results may differ materially from expectations due to inherent business risks and uncertainties.
About Greater Cannabis Company, Inc.
The Greater Cannabis Company develops and commercializes cannabinoid therapeutics, focusing on innovative drug delivery platforms and neuropsychiatric treatments. It holds licenses for cannabinoid-based therapies targeting conditions like autism and Parkinson’s disease. The company operates in the medical cannabis sector, emphasizing research, clinical development, and strategic partnerships, with a business model centered on developing proprietary therapeutics and licensing technologies in a highly regulated industry.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.